Table 2.
Variable | Univariable | Multivariable | ||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
HR | 95% CI | Pa | Overall Pa | HR | 95% CI | P | Overall P | |
Age | 1.03 | 1.02–1.05 | <0.0001 | 1.03 | 1.02–1.04 | <0.0001 | ||
Sex: male vs female | 1.47 | 1.20–1.79 | 0.0002 | 1.36 | 1.11–1.66 | 0.003 | ||
Smoking status | ||||||||
Never | 1.00 | — | — | 0.089 | ||||
Former | 1.16 | 0.88–1.54 | 0.3 | |||||
Current | 1.51 | 1.04–2.18 | 0.030 | |||||
Extent of resection | ||||||||
Lobectomy/bilobectomy | 1.00 | — | — | <0.0001 | 1.00 | — | — | <0.0001 |
Pneumonectomy | 1.77 | 0.89–3.53 | 0.106 | 1.60 | 0.79–3.23 | 0.2 | ||
Segmentectomy | 1.61 | 1.12–2.33 | 0.011 | 1.65 | 1.14–2.39 | 0.008 | ||
Wedge | 2.05 | 1.54–2.72 | <0.0001 | 2.09 | 1.55–2.81 | <0.0001 | ||
Pathologic stage | ||||||||
IA | 1.00 | — | — | <0.0001 | 1.00 | — | — | <0.0001 |
IB | 1.86 | 1.48–2.34 | <0.0001 | 1.50 | 1.16–1.93 | 0.002 | ||
IIA | 2.67 | 1.81–3.94 | <0.0001 | 2.24 | 1.47–3.39 | 0.0002 | ||
IIB/IIIA | 3.96 | 2.92–5.38 | <0.0001 | 3.15 | 2.15–4.63 | <0.0001 | ||
Gross tumor size, cm | 1.08 | 0.99–1.17 | 0.073 | 1.06 | 0.98–1.16 | 0.2 | ||
Lymphovascular invasion | 1.52 | 1.22–1.90 | 0.0002 | 1.38 | 1.09–1.74 | 0.007 | ||
IASLC predominant subtype | ||||||||
Lepidic | 1.00 | — | — | 0.016 | 1.00 | — | — | 0.3 |
Acinar | 1.57 | 0.99–2.49 | 0.055 | 1.35 | 0.84–2.17 | 0.2 | ||
Papillary | 1.74 | 1.08–2.81 | 0.023 | 1.45 | 0.90–2.36 | 0.13 | ||
Micropapillary | 2.41 | 1.41–4.11 | 0.001 | 1.78 | 1.02–3.11 | 0.044 | ||
Solid | 1.89 | 1.15–3.10 | 0.012 | 1.51 | 0.90–2.52 | 0.12 | ||
Architectural grade | ||||||||
Low | 1.00 | — | — | 0.008 | ||||
Intermediate | 1.63 | 1.04–2.56 | 0.033 | |||||
High | 2.05 | 1.27–3.30 | 0.003 | |||||
BRMS1 score: low vs high | 1.37 | 1.12–1.67 | 0.002 | 1.36 | 1.11–1.67 | 0.003 |
CI, confidence interval; HR, hazard ratio.
P is from a model stratified by pathologic stage.